CAPTRUST Financial Advisors
BPMC

CAPTRUST Financial Advisors’s Blueprint Medicines BPMC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,909
Closed -$700K – 2521
2025
Q1 		$700K Sell
7,909
-422
-5% -$41.2K ﹤0.01% 1460
2024
Q4 		$727K Sell
8,331
-9,573
-53% -$877K ﹤0.01% 1407
2024
Q3 		$1.66M Buy
17,904
+582
+3% +$57.8K ﹤0.01% 933
2024
Q2 		$1.87M Sell
17,322
-7,801
-31% -$781K 0.01% 855
2024
Q1 		$2.38M Sell
25,123
-13,625
-35% -$1.17M 0.01% 735
2023
Q4 		$3.57M Sell
38,748
-12,720
-25% -$824K 0.01% 676
2023
Q3 		$2.58M Buy
51,468
+1,663
+3% +$88.9K 0.01% 758
2023
Q2 		$3.15M Buy
49,805
+22,227
+81% +$1.21M 0.01% 660
2023
Q1 		$1.24M Buy
27,578
+8,316
+43% +$375K 0.01% 928
2022
Q4 		$844K Buy
19,262
+2,219
+13% +$106K ﹤0.01% 1063
2022
Q3 		$1.12M Sell
17,043
-31
-0.2% -$1.99K 0.01% 863
2022
Q2 		$862K Buy
17,074
+868
+5% +$50.8K 0.01% 907
2022
Q1 		$1.03M Buy
16,206
+401
+3% +$28.8K 0.01% 842
2021
Q4 		$1.69M Buy
15,805
+964
+6% +$101K 0.01% 613
2021
Q3 		$1.53M Buy
14,841
+2,503
+20% +$233K 0.01% 599
2021
Q2 		$1.08M Hold
12,338
– – 0.01% 689
2021
Q1 		$1.2M Buy
12,338
+131
+1% +$13.1K 0.01% 629
2020
Q4 		$1.37M Sell
12,207
-674
-5% -$71K 0.02% 499
2020
Q3 		$1.21M Hold
12,881
– – 0.02% 450
2020
Q2 		$1.02M Buy
12,881
+1,600
+14% +$108K 0.02% 497
2020
Q1 		$644K Buy
11,281
+80
+0.7% +$5.15K 0.01% 522
2019
Q4 		$921K Buy
+11,201
New +$839K 0.01% 519

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAPTRUST Financial Advisors's BPMC Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 7,909 shares — an estimated $700K sold.

CAPTRUST Financial Advisors first reported a position in BPMC in Q4 2019 and held it in 22 quarters. The position peaked at $3.57M in Q4 2023. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 7,909 Blueprint Medicines shares in Q2 2025, an estimated $700K.
  • CAPTRUST Financial Advisors first reported a position in Blueprint Medicines in Q4 2019 and held it in 22 quarters.
  • CAPTRUST Financial Advisors's Blueprint Medicines position peaked at $3.57M in Q4 2023.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.